Literature DB >> 1374843

The effect of orientation of epitopes on the immunogenicity of chimeric synthetic peptides representing measles virus protein sequences.

C Partidos1, C Stanley, M Steward.   

Abstract

We have studied the influence of the orientation of T- and B-cell epitopes on the immunogenicity of chimeric synthetic peptides in terms of the ability of the T-cell epitope to provide help for the production of antibody to the B-cell epitope. A T-cell epitope from the fusion protein of measles virus (288-302), previously shown to act as a T-helper epitope in a panel of six inbred mouse strains, was co-linearly synthesized at either the amino- or carboxyl- terminus of a B-cell epitope from the haemagglutinin of the virus (188-199) with or without the inclusion of a glycine-glycine spacer. The four chimeric peptides were used to immunize a panel of five mouse strains and induced good anti-chimera antibody responses. In general, the chimeras in which the T-cell epitope was amino-terminal to the B-cell epitope induced antibodies which bound well to the B-cell epitope whereas the carboxyl-terminal orientation of the T-cell epitope with respect to the B-cell epitope failed to induce such antibody. These latter chimeras induced the production of antibodies which preferentially bound to the T-cell epitope. The inclusion of the gly-gly spacer in the chimeras did not enhance their immunogenicity nor did it increase antibody titres to the B-cell epitope. The affinity of the anti-peptide antibodies was markedly influenced by the orientation of the epitopes in the chimeras. The antibody elicited by the peptide in which the T-cell epitope was amino terminal to the B-cell epitope had significantly higher affinity for the B-cell epitope than that induced by immunization with the peptide in the reverse orientation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374843     DOI: 10.1016/0161-5890(92)90202-9

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  6 in total

1.  Antibody responses to non-immunogenic synthetic peptides induced by co-immunization with immunogenic peptides.

Authors:  C D Partidos; O E Obeid; M W Steward
Journal:  Immunology       Date:  1992-10       Impact factor: 7.397

2.  A strategy for rational design of fully synthetic glycopeptide conjugate vaccines.

Authors:  P Chong; N Chan; A Kandil; B Tripet; O James; Y P Yang; S P Shi; M Klein
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

3.  Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus.

Authors:  O E Obeid; C D Partidos; C R Howard; M W Steward
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

4.  An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain.

Authors:  J S Wolinsky; E Sukholutsky; W T Moore; A Lovett; M McCarthy; B Adame
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

5.  Enhanced immunogenicity of a functional enzyme by T cell epitope modification.

Authors:  Jeanette M Mucha; Marcia M Stickler; A J Poulose; Grant Ganshaw; Mae Saldajeno; Kathy Collier; Manley T Huang; Fiona A Harding
Journal:  BMC Immunol       Date:  2002-01-25       Impact factor: 3.615

6.  On the meaning of affinity limits in B-cell epitope prediction for antipeptide antibody-mediated immunity.

Authors:  Salvador Eugenio C Caoili
Journal:  Adv Bioinformatics       Date:  2012-11-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.